Brady Todd C

Brady Todd C is listed in filings as President and CEO at Aldeyra Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including purchase activity. Recent filings connect the profile to Aldeyra Therapeutics, Inc. (ALDX). The current snapshot covers public activity from Mar 31, 2026 to Jun 5, 2026. Reported amounts are shown as $418.4K to $3.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.